[1] 徐京杭, 于岩岩, 徐小元. 肝硬化研究进展和展望. 中华肝脏病杂志, 2021,29(02):108-110. [2] 田彩云, 胡晗, 张国远, 等. 肝源性糖尿病的诊断研究进展. 中国全科医学, 2021,24(09):1158-1164. [3] 徐小元,丁惠国,李文刚,徐京杭,韩莹,贾继东,魏来,段钟平,令狐恩强,庄辉.肝硬化诊治指南.临床肝胆病杂志,2019,35(11):2408-2425. [4] 中国2型糖尿病防治指南(2017年版). 中华糖尿病杂志, 2018,10(01):4-67. [5] Mokdad AA, Lopez AD, Shahraz S, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med, 2014,12:145. [6] Petit JM, Hamza S, Rollot F, et al. Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosis. Acta Diabetol, 2014,51(3):455-460. [7] 秦用梅,温晓雅,绳利华.肝硬化合并肝源性糖尿病患者的观察与护理.青岛医药卫生,2013,45(06):454-455. [8] 张华征, 邢向荣, 张宁苏. 大肠癌合并贫血相关因素分析与中医证型分布的临床研究. 实用中医内科杂志, 2020,34(05):127-130. [9] 丰浩田, 丰义宽, 田强, 等. 老年肝硬化并发糖尿病的临床特点及相关因素Logistic分析. 中国老年学杂志, 2013,33(12):2924-2925. [10] 刘丽, 江颖仪, 刘景. 不同Child-Pugh分级慢性乙型肝炎肝硬化患者糖代谢、胰岛素分泌情况及其与炎症反应的相关性分析. 临床肝胆病杂志, 2020,36(02):324-328. [11] 于婧璐, 侯丽辉, 孙淼, 等. 不同体重指数的多囊卵巢综合征患者的临床特征差异性分析. 中国医药导报, 2020,17(26):75-78. [12] 湛兵兵.113例肝硬化合并肝源性糖尿病临床特点分析.临床医药文献电子杂志,2019,6(49):80. [13] Jepsen P, Watson H, Andersen PK, et al. Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients. J Hepatol, 2015,63(5):1133-1138. [14] Qi X, Peng Y, Li H, et al. Diabetes is associated with an increased risk of in-hospital mortality in liver cirrhosis with acute upper gastrointestinal bleeding. Eur J Gastroenterol Hepatol, 2015,27(4):476-477. [15] Wlazlo N, van Greevenbroek MM, Curvers J, et al. Diabetes mellitus at the time of diagnosis of cirrhosis is associated with higher incidence of spontaneous bacterial peritonitis, but not with increased mortality. Clin Sci (Lond), 2013,125(7):341-348. [16] Coman LI, Coman OA, Badarau IA, et al. Association between liver cirrhosis and diabetes mellitus: a review on hepatic outcomes. J Clin Med, 2021,10(2). [17] 唐淬蓉, 胡承光, 周宇辰, 等. 乙型肝炎肝硬化合并糖尿病时发生肝细胞癌的风险:一项随访5年的前瞻性队列研究. 南方医科大学学报, 2021,41(03):313-318. |